These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9382536

  • 1. [Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma].
    Higuchi K, Onda M, Furukawa K, Minobe K, Tanaka N, Arima Y, Hasegawa H.
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1799-802. PubMed ID: 9382536
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 Sep; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 3. [Neoadjuvant intra-arterial infusion chemotherapy in over stage III and inflammatory carcinoma of the breast].
    Higuchi K, Onda M, Furukawa K, Minobe K, Tanaka N, Arima Y.
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1533-6. PubMed ID: 8854799
    [Abstract] [Full Text] [Related]

  • 4. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast.
    Schwartz GF, Meltzer AJ, Lucarelli EA, Cantor JP, Curcillo PG.
    J Am Coll Surg; 2005 Sep; 201(3):327-34. PubMed ID: 16125064
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic effect of stage III breast cancer--comparative study of preoperative intra-arterial infusion chemotherapy and non-infusion therapy].
    Masuoka H, Asaishi K, Toda K, Okazaki M, Okazaki Y, Hayasaka H, Miyake H, Mori M.
    Gan To Kagaku Ryoho; 1989 May; 16(5):2067-73. PubMed ID: 2543329
    [Abstract] [Full Text] [Related]

  • 6. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
    Conti F, Carpano S, Sergi D, Di Lauro L, Amodio A, Vici P, Abbate MI, Ferranti FR, Viola G, Botti C, Foggi P, Sperduti I, Lopez M.
    Clin Ter; 2007 May; 158(4):331-41. PubMed ID: 17953285
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R, Osaki A, Tanabe K, Toge T.
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 9. [Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers].
    Okazaki M, Okazaki A, Masuoka H, Toda K, Yamada T, Okazaki Y, Asaishi K, Hirata K, Narimatsu E.
    Gan To Kagaku Ryoho; 1995 Apr 12; 22 Suppl 1():94-101. PubMed ID: 7747999
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.
    Br J Cancer; 2000 Dec 12; 83(11):1480-7. PubMed ID: 11076657
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
    Blumenschein GR, DiStefano A, Caderao J, Fristenberg B, Adams J, Schweichler LH, Drinkard L.
    Clin Cancer Res; 1997 Dec 12; 3(12 Pt 2):2633-7. PubMed ID: 10068266
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Cho N, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    Breast Cancer Res Treat; 2009 Jul 12; 116(1):153-60. PubMed ID: 18787948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The significance of intra-arterial infusion therapy for neoadjuvant chemotherapy].
    Asaishi K, Okazaki M, Okazaki A, Toda K, Masuoka H, Hirata K, Narimatsu E.
    Gan To Kagaku Ryoho; 1994 Jun 12; 21 Suppl 2():264-71. PubMed ID: 8037491
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.
    Am Surg; 2005 Jun 12; 71(6):487-92. PubMed ID: 16044927
    [Abstract] [Full Text] [Related]

  • 18. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
    Mikhak B, Zahurak M, Abeloff MD, Fetting JH, Davidson NE, Donehower RC, Waterfield W, Kennedy MJ.
    Cancer; 1999 Feb 15; 85(4):899-904. PubMed ID: 10091768
    [Abstract] [Full Text] [Related]

  • 19. Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer.
    Honkoop AH, Luykx-de Bakker SA, Hoekman K, Meyer S, Meyer OW, van Groeningen CJ, van Diest PJ, Boven E, van der Wall E, Giaccone G, Wagstaff J, Pinedo HM.
    Oncologist; 1999 Feb 15; 4(2):106-11. PubMed ID: 10337380
    [Abstract] [Full Text] [Related]

  • 20. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.
    Coskun U, Gunel N, Onuk E, Yilmaz E, Bayram O, Yamac D, Cihan A, Ucan B, Yildirim Y, Celenkoglu G, Ozkan S.
    Neoplasma; 2003 Feb 15; 50(3):210-6. PubMed ID: 12937855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.